全文获取类型
收费全文 | 52075篇 |
免费 | 5993篇 |
国内免费 | 918篇 |
专业分类
耳鼻咽喉 | 747篇 |
儿科学 | 1523篇 |
妇产科学 | 1028篇 |
基础医学 | 3095篇 |
口腔科学 | 1763篇 |
临床医学 | 9759篇 |
内科学 | 7372篇 |
皮肤病学 | 910篇 |
神经病学 | 5014篇 |
特种医学 | 632篇 |
外国民族医学 | 5篇 |
外科学 | 5252篇 |
综合类 | 5485篇 |
现状与发展 | 6篇 |
一般理论 | 6篇 |
预防医学 | 7329篇 |
眼科学 | 560篇 |
药学 | 2324篇 |
95篇 | |
中国医学 | 1613篇 |
肿瘤学 | 4468篇 |
出版年
2024年 | 120篇 |
2023年 | 1198篇 |
2022年 | 1862篇 |
2021年 | 2788篇 |
2020年 | 3024篇 |
2019年 | 2912篇 |
2018年 | 2661篇 |
2017年 | 2719篇 |
2016年 | 2610篇 |
2015年 | 2337篇 |
2014年 | 3998篇 |
2013年 | 4509篇 |
2012年 | 3139篇 |
2011年 | 3090篇 |
2010年 | 2322篇 |
2009年 | 2534篇 |
2008年 | 2469篇 |
2007年 | 2454篇 |
2006年 | 2065篇 |
2005年 | 1758篇 |
2004年 | 1424篇 |
2003年 | 1207篇 |
2002年 | 907篇 |
2001年 | 815篇 |
2000年 | 634篇 |
1999年 | 466篇 |
1998年 | 446篇 |
1997年 | 366篇 |
1996年 | 324篇 |
1995年 | 283篇 |
1994年 | 225篇 |
1993年 | 211篇 |
1992年 | 193篇 |
1991年 | 127篇 |
1990年 | 114篇 |
1989年 | 118篇 |
1988年 | 99篇 |
1987年 | 67篇 |
1986年 | 55篇 |
1985年 | 64篇 |
1984年 | 49篇 |
1983年 | 30篇 |
1982年 | 30篇 |
1981年 | 33篇 |
1980年 | 23篇 |
1979年 | 16篇 |
1977年 | 14篇 |
1976年 | 16篇 |
1975年 | 10篇 |
1968年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的:通过中英文文献了解结直肠癌患者生命质量研究现状及发展趋势。方法:运用CiteSpace对中国知网(CNKI)、万方数据知识服务平台、中国生物医学文献数据库、Web of Science核心数据集、PubMed、Cochrane Library中收录的关于结直肠癌患者生命质量研究的中英文文献进行可视化分析。结果:检索得到中文文献1 285篇,英文文献871篇,中英文文献发文量均呈上升趋势,相关研究关注的重点主要是结直肠癌患者造口、抑郁、免疫、肠道功能、化疗及化疗药物,但机构之间、学者之间合作程度及研究类型等方面存在一定差异。结论:中文文献相关研究起步晚、发展快,但在研究质量与研究深度等方面与英文文献相比还有一定差距;国内学者之间、机构之间应加强合作,关心患者肠道功能、心理状况,提高患者体力活动水平,开展更多高质量研究。 相似文献
2.
3.
4.
《Journal of vascular and interventional radiology : JVIR》2021,32(10):1449-1456
PurposeTo investigate the safety and efficacy of thyroid artery embolization (TAE) in the treatment of nodular goiter (NG).MethodsDuring a 5.5-year period, 56 consecutive patients with a NG underwent TAE. In Group A, there were 20 patients with a solitary/dominant 5–11-cm nodule, and in Group B, there were 36 patients with numerous nodules. Of the 56 patients, 47 (84%) had a retrosternal goiter and 25 had hyperthyroidism. In all patients, clinical and radiological evaluations were made at baseline and 6 months after TAE, and these parameters were statistically compared.ResultsIn 56 patients, 145 of the 146 thyroid arteries were successfully embolized. The 30-day mortality rate was 1.8%. Minor and major complications occurred in 25 and 2 patients, respectively. Six months after the TAE, the mean nodule volume was reduced from 80.2 mL to 25.0 mL, the mean thyroid volume was reduced from 147.0 mL to 62.6 mL, and the mean intrathoracic extension was reduced from 31.7 mm to 15.9 mm (P < .001). Of the 22 patients with non–Graves hyperthyroidism, 19 (86%) became euthyroid. The mean thyroid-related patient-reported outcome scores improved from 155.4 to 70.4 (P < .001). Of the 51 patients, 50 (98%) declared that they would recommend TAE to other patients with NG.ConclusionsTAE is safe and effective for the treatment of NG, with a significant volume reduction of the nodule(s) and thyroid gland. 相似文献
5.
Karen Kayser Ariel Washington Lesley M. Harris Barbara Head 《Journal of psychosocial oncology》2021,39(1):17-34
Abstract
Purpose
Financial hardship can be a major cause of distress among persons with cancer, resulting in chronic stress and impacting physical and emotional health. This paper provides an analysis of the lived experience of cancer patients’ financial hardship from diagnosis to post-treatment. 相似文献6.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
7.
8.
9.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
10.